General Information of Drug (ID: DM4YSMK)

Drug Name
V212
Indication
Disease Entry ICD 11 Status REF
Herpes zoster 1E91 Phase 3 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D2WT8Y

References

1 ClinicalTrials.gov (NCT01229267) A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001). U.S. National Institutes of Health.